← Evidence map

ArticleInvestigational new drugs2012

Two-stage model-based design of cancer phase I dose escalation trials: evaluation using the phase I program of barasertib (AZD1152).

Ron J Keizer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

this papercites it

Two-stage model-based design of cancer phase I dose escalation trials: evaluation using the phase I program of barasertib (AZD1152). | OpenQuestion